Humoral and cellular CMV responses in healthy donors; identification of a frequent population of CMV-specific, CD4+ T cells in seronegative donors.
CMV status is an important risk factor in immune compromised patients. In hematopoeitic cell transplantations (HCT), both donor and recipient are tested routinely for CMV status by serological assays; however, one might argue that it might also be of relevance to examine CMV status by cellular (i.e....
Main Authors: | Nina Loeth, Kristian Assing, Hans O Madsen, Lars Vindeløv, Soren Buus, Anette Stryhn |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3274531?pdf=render |
Similar Items
-
Effect of ageing on CMV-specific CD8 T cells from CMV seropositive healthy donors
by: Alonso Corona, et al.
Published: (2009-08-01) -
Comparison of Humoral and Cellular CMV Immunity in Patients Awaiting Kidney Transplantation
by: Monika Lindemann, et al.
Published: (2021-09-01) -
Is seroprevalence of anti-IGM CMV among blood donors relevant in India?
by: Kumar Harsh, et al.
Published: (2008-07-01) -
How Do Donor-recipient CMV Serostatus and Post-hematopoietic Stem Cell Transplantation CMV Reactivation Affect Outcomes in Acute Leukemia Patients?
by: Mohammad Vaezi, et al.
Published: (2016-10-01) -
Protective Cytomegalovirus (CMV)-Specific T-Cell Immunity Is Frequent in Kidney Transplant Patients without Serum Anti-CMV Antibodies
by: Nicolle H. R. Litjens, et al.
Published: (2017-09-01)